Zimmer Biomet Holdings, Inc.

ZBH Healthcare Medical Devices

Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024. In the quarter to June 2026, revenue grew 4.80%, EPS grew 33.8%, free cash flow grew 13.1% and total debt fell 1.23%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five.

95.06 0.68 +0.72%
Market cap
$18.0B
P/E
23.0×
Fwd P/E
17.7×
Dividend yield
1.01%
F-score
6/9
Altman Z
2.38
Beneish M
−2.59
Dividend safety
72/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

24.26 25.19 23.36 20.85
P/S ratio
2.44 2.16 2.10 1.94
P/FCF ratio
19.29 16.53 17.49 15.96
P/Operating CF
46.60 34.41 49.06 36.95
P/B ratio
1.53 1.40 1.39 1.31
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
3.29 3.00 2.93 2.78
EV/EBITDA
10.94 11.28 10.78 10.21
EV/Operating CF
15.62 14.57 14.75 13.55
EV/FCF
26.04 22.96 24.48 22.78
Quick Ratio
1.20 0.89 0.75 0.72
Current Ratio
2.43 1.98 1.73 1.69
Net Debt/EBITDA
10.74 15.80 10.96 11.84
Debt/Assets
34.54% 32.56% 32.88% 32.81%
Debt/Equity
0.64 0.59 0.59 0.59
Asset Turnover
0.35 0.37 0.37 0.37
Operating CF/Net income
1.81 3.71 1.51 2.26
Capex/Depreciation
(0.53) (0.71) (0.56) (0.75)
Interest Coverage
4.66 2.15 5.42 4.47
Research and Development Expense of Revenue
5.79% 5.29% 4.96% 4.81%
Selling, General and Administrative Expense of Revenue
40.54% 38.87% 40.73% 41.31%
Intangible Assets out of Total Assets
0.61 0.64 0.64 0.63
Share Based Compensation of Revenue
1.26% 1.07% 1.16% 1.13%
Graham Net Nets
(0.25) (0.30) (0.29) (0.31)
Graham Number
76.73 71.79 75.25 78.15
Earnings Yield
4.12% 3.97% 4.28% 4.80%
Free Cash Flow Yield
5.18% 6.05% 5.72% 6.26%
Revenue per Share
10.10 11.33 10.70 11.33
Operating CF per Share
2.11 2.61 1.84 2.33
Capex per Share
(0.76) (1.02) (0.78) (1.05)
Free Cash Flow per Share
1.35 1.60 1.06 1.28
Cash per Share
6.53 2.99 2.18 2.13
Shareholders Equity per Share
64.44 64.17 65.03 65.73
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
64.44 64.17 65.03 65.73
Free Cash Flow
267.70 315.90 206.90 246.00
Working Capital
3,432.00 2,536.20 2,098.20 2,083.20
Capital Expenditures
(151.00) (201.50) (152.50) (201.80)
Net Current Asset Value
(4,887.10) (5,266.10) (5,077.50) (5,068.60)
EV/EBIT
19.76 22.52 20.93 19.60
Capex to Sales
0.08 0.09 0.07 0.09
Price to Operating Income
14.64 16.21 14.96 13.73
Other line items
Average Receivables
1,539.90 1,592.55 1,631.00 1,690.40
Average Payables
318.85 248.80 331.25 350.55
Average Inventory
2,426.20 2,260.85 2,245.50 2,362.25
Average Assets
22,604.15 22,228.50 22,452.75 22,831.45
Average Common Equity
12,574.60 12,591.00 12,542.65 12,583.45

Fold the line items

Columns are period end dates